$ATOS late news yesterday.. 10 million from exercises outstanding warrants. Partnerships tend to be common for clinical stage biotechs. Cash up front, milestones, reimbursement for R&D typical. Pathway to monetize drug. Continuation continues imo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.